Ouabain: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | <!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
<Structure load='3n23' size='500' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' /> | <Structure load='3n23' size='500' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' /> | ||
=Ouabain= | |||
<scene name='Sandbox_60/Ouabain_3d/1'>Ouabain</scene> is a cardiac glycoside that inhibits the ATP-dependent sodium-potassium exchange across cell membranes. | <scene name='Sandbox_60/Ouabain_3d/1'>Ouabain</scene> is a cardiac glycoside that inhibits the ATP-dependent sodium-potassium exchange across cell membranes. The binding of ouabain to the sodium-potassium pump prevents the conformational changes necessary for its function. This affects intracellular ion composition in various ways, depending on the cell and the dosage. The compound has therefore been utilized in medicine, both as a drug and in research related to active membrane transport. Its has also been proven effective for original use; as a poison. | ||
[[Image:Ouabain.png]] | |||
